John M. Evans Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John M. Evans.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John M. Evans. John M. Evans is CEO in Beam Therapeutics Inc. ($BEAM) and Chief Executive Officer in Beam Therapeutics Inc. ($BEAM).
Latest Insider Trading Transactions of John M. Evans
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Option Exercise | M | 1.03 | 6,000 | 6,180 | 396,345 | |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Buy | M | 1.03 | 6,000 | 6,180 | 1,021,429 | 1 M to 1 M (+0.59 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Option Exercise | M | 1.03 | 6,000 | 6,180 | 396,345 | |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 71.79 | 2,994 | 214,939 | 1,015,429 | 1 M to 1 M (-0.29 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Buy | M | 1.03 | 6,000 | 6,180 | 1,021,429 | 1 M to 1 M (+0.59 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 71.38 | 9,869 | 704,449 | 1,018,423 | 1 M to 1 M (-0.96 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 71.79 | 2,994 | 214,939 | 1,015,429 | 1 M to 1 M (-0.29 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 70.23 | 5,595 | 392,937 | 1,028,292 | 1 M to 1 M (-0.54 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 71.38 | 9,869 | 704,449 | 1,018,423 | 1 M to 1 M (-0.96 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 69.02 | 5,079 | 350,553 | 1,033,887 | 1 M to 1 M (-0.49 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 70.23 | 5,595 | 392,937 | 1,028,292 | 1 M to 1 M (-0.54 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 67.90 | 1,463 | 99,338 | 1,038,966 | 1 M to 1 M (-0.14 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 69.02 | 5,079 | 350,553 | 1,033,887 | 1 M to 1 M (-0.49 %) |
Apr 23 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 67.90 | 1,463 | 99,338 | 1,038,966 | 1 M to 1 M (-0.14 %) |
Apr 12 2021 | BEAM | Beam Therapeutics ... | Evans John M. | Chief Executive Off ... | Buy | L | 0.00 | 32 | 0 | 1,040,429 | 1 M to 1 M (0.00 %) |
Apr 12 2021 | BEAM | Beam Therapeutics ... | Evans John M. | Chief Executive Off ... | Buy | L | 0.00 | 32 | 0 | 1,040,397 | 1 M to 1 M (0.00 %) |
Apr 12 2021 | BEAM | Beam Therapeutics ... | Evans John M. | Chief Executive Off ... | Buy | L | 0.00 | 33 | 0 | 1,040,365 | 1 M to 1 M (0.00 %) |
Apr 02 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Option Exercise | A | 80.04 | 138,750 | 11,105,550 | 138,750 | |
Apr 02 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Grant | A | 0.00 | 69,375 | 0 | 1,040,332 | 971 K to 1 M (+7.15 %) |
Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 89.41 | 1,666 | 148,957 | 970,957 | 972.6 K to 971 K (-0.17 %) |
Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 88.12 | 1,121 | 98,783 | 972,623 | 973.7 K to 972.6 K (-0.12 %) |
Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 86.79 | 504 | 43,742 | 973,744 | 974.2 K to 973.7 K (-0.05 %) |
Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 86.21 | 7,196 | 620,367 | 974,248 | 981.4 K to 974.2 K (-0.73 %) |
Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 85.35 | 1,422 | 121,368 | 981,444 | 982.9 K to 981.4 K (-0.14 %) |
Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 83.76 | 4,925 | 412,518 | 982,866 | 987.8 K to 982.9 K (-0.50 %) |
Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 82.33 | 4,100 | 337,553 | 987,791 | 991.9 K to 987.8 K (-0.41 %) |
Jan 04 2021 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Sell | S | 81.14 | 1,366 | 110,837 | 991,891 | 993.3 K to 991.9 K (-0.14 %) |
Aug 17 2020 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Option Exercise | M | 1.03 | 115,000 | 118,450 | 402,345 | |
Aug 17 2020 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Buy | M | 1.03 | 115,000 | 118,450 | 993,257 | 878.3 K to 993.3 K (+13.09 %) |
Aug 17 2020 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Option Exercise | M | 1.03 | 115,000 | 118,450 | 402,345 | |
Aug 17 2020 | BEAM | Beam Therapeutics ... | Evans John M. | CEO | Buy | M | 1.03 | 115,000 | 118,450 | 993,257 | 878.3 K to 993.3 K (+13.09 %) |
Page: 1